Syndax Pharmaceuticals (SNDX)

$23.48

-0.02

(-0.09%)

Market is closed - opens 7 PM, 15 Jul 2024

Insights on Syndax Pharmaceuticals

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 81.1% return, outperforming this stock by 66.3%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 227.9% return, outperforming this stock by 183.1%

Performance

  • $23.22
    $23.96
    $23.48
    downward going graph

    1.11%

    Downside

    Day's Volatility :3.09%

    Upside

    2.0%

    downward going graph
  • $11.22
    $25.34
    $23.48
    downward going graph

    52.21%

    Downside

    52 Weeks Volatility :55.72%

    Upside

    7.34%

    downward going graph

Returns

PeriodSyndax PharmaceuticalsSector (Health Care)Index (Russel 2000)
3 Months
8.6%
6.7%
0.0%
6 Months
5.01%
5.5%
0.0%
1 Year
14.76%
14.3%
0.0%
3 Years
44.85%
15.1%
-21.0%

Highlights

Market Capitalization
2.0B
Book Value
$5.79
Earnings Per Share (EPS)
-3.24
PEG Ratio
0.0
Wall Street Target Price
34.73
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-32.84%
Return On Equity TTM
-51.9%
Revenue TTM
126.6M
Revenue Per Share TTM
2.17
Quarterly Revenue Growth YOY
33297.4%
Gross Profit TTM
139.7M
EBITDA
-263.4M
Diluted Eps TTM
-3.24
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.57
EPS Estimate Next Year
-2.93
EPS Estimate Current Quarter
-0.98
EPS Estimate Next Quarter
-1.04

Analyst Recommendation

Buy
    89%Buy
    10%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Syndax Pharmaceuticals(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
17
17
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 47.91%

Current $23.48
Target $34.73

Technicals Summary

Sell

Neutral

Buy

Syndax Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Syndax Pharmaceuticals
Syndax Pharmaceuticals
13.43%
5.01%
14.76%
44.85%
161.47%
Moderna, Inc.
Moderna, Inc.
-16.37%
18.89%
-4.07%
-48.35%
748.18%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
7.16%
17.36%
52.58%
90.65%
268.9%
Novo Nordisk A/s
Novo Nordisk A/s
-0.29%
33.6%
81.13%
227.9%
496.35%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
2.03%
11.71%
40.03%
146.43%
177.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Syndax Pharmaceuticals
Syndax Pharmaceuticals
0.0
NA
0.0
-3.57
-0.52
-0.33
NA
5.79
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.64
31.64
1.46
44.29
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
49.22
49.22
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.94
31.94
0.53
17.02
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Buy
$2.0B
161.47%
0.0
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$47.1B
748.18%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$118.0B
268.9%
31.64
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$635.7B
496.35%
49.22
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.9B
177.11%
31.94
39.46%

Institutional Holdings

  • BlackRock Inc

    8.89%
  • Wellington Management Company LLP

    8.75%
  • Kynam Capital Management, LP

    6.66%
  • Vanguard Group Inc

    5.80%
  • State Street Corporation

    5.67%
  • venBio Select Advisor LLC

    4.97%

Company Information

syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.

Organization
Syndax Pharmaceuticals
Employees
184
CEO
Mr. Michael A. Metzger M.B.A.
Industry
Health Technology

FAQs